Current options for the topical treatment of acne vulgaris

Pediatric Dermatology

Volumn 14, Issue 6, 1997, Pages 480-488

  Weiss, Jonathan S ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Gwinnett Dermatology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPALENE; AZELAIC ACID; RETINOIC ACID; TAZAROTENE;

ACNE VULGARIS; ANTIBIOTIC THERAPY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACTERIUM CONTAMINATION; CLINICAL FEATURE; DRUG EFFECT; DRUG FORMULATION; HUMAN; HYPERKERATOSIS; PRIORITY JOURNAL; PROPIONIBACTERIUM ACNES; TESTOSTERONE BLOOD LEVEL; TREATMENT PLANNING;

EID: 0031450920     PISSN: 07368046     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-1470.1997.tb00696.x     Document Type: Article

References (44)

1. Yonkosky DM, Pochi PE. Acne vulgaris in childhood: pathogenesis and management. Dermatol Clin 1986;4: 127-136.
2. Kranung KK, Oland GF, eds. Prevalence, morbidity, and cost of dermatologic disease. J Invest Dermatol 1979;73: 394-441.
3. Data on file, Ortho-McNeill Pharmaceuticals; Penederm.
4. Cunliffe WJ, Holland KT. Clinical laboratory studies on treatment with 20% azelaic acid cream for acne. Acta Dermatol Venerol (Stockh) 1989;143(suppl):31-34.
5. Mayer-Da-Silva A, Gollnick H, Detmar M, et al. Effects of azelaic acid on sebaceous gland, sebum excretion rate and keratinization pattern in human skin. An in vivo and in vitro study. Acta Dermatol Venerol (Stockh) 1989;143 (suppl):20-30.
6. Knutson DD. Ultrastructural observation in acne vulgaris. The normal sebaceous follicle and acne lesions. J Invest Dermatol 1974;62:288-307.
7. Lever L, Marks R. Current views on the aetiology, pathogenesis, and treatment of acne vulgaris. Drugs 1990;39: 681-692.
8. Lee PA. Acne and serum androgens during puberty. Arch Dermatol 1976;112:482-484.
9. Pochi PE, Strauss JS, Downing DT. Skin surface lipid composition, acne, pubertal development, and urinary secretion of testosterone and 17-ketosteroids in children. J Invest Dermatol 1977;69:485-489.
10. Darley C. Recent advances in hormonal aspects of acne vulgaris. Int J Dermatol 1984;23:539-541.
11. Sansone G, Reuner RM. Differential rates of conversion of testosterone to dihydrotestosterone in acne and in normal skin. J Invest Dermatol 1971;56:366-372.
12. Leyden JJ, Kligman AM. The role of bacteria in acute acne vulgaris. In: Fleischmajer R, ed. Progress in diseases of the skin, vol. 2. New York: Grune & Stratton, 1984:21-29.
13. Shalita AR, Lee WL. Inflammatory acne. Dermatol Clin 1983;1:361-364.
14. Berg M, Ledern S. An epidemiological study of rosacea. Acta Dermatol Venereol (Stockh) 1989;69:419-423.
15. Orfanos CE, Ehlert R, Gollnick H. The retinoids. A review of their clinical pharmacology and therapeutic use. Drugs 1987;34:459-503.
16. Mills OH, Kligman AM. Treatment of acne vulgaris with topically applied erythromycin and tretinoin. Acta Dermatol Venereol (Stockh) 1978;58:555-557.
17. Shalita A, Weiss JS, Chalker DK, et al. A comparison of the efficacy and safety of adapalene gel 0.1% and tretinoin gel 0.025% in the treatment of acne vulgaris: a multicenter trial. J Am Acad Dermatol 1996;34:482-485.
18. Gibson JR. Rationale for the development of new topical treatments for acne vulgaris. Cutis 1996;57(1S):13-19.
19. Hurwitz S. Tretinoin (vitamin A acid) and benzoyl peroxide in the treatment of acne vulgaris. J Clin Dermatol 1994;September(suppl):10-12.
20. Rittmaster RS. Hyperandrogenism. In: Copeland LJ, et al., eds. Textbook of gynecology. Philadelphia: WB Saunders, 1993:414-446.
21. Fulton JE Jr, Farzad-Bakshandeh A, Bradley S, et al. Studies on the mechanism of action of topical benzoyl peroxide and vitamin A acid in acne vulgaris. J Cutan Pathol 1974; 1:191.
22. Rietschel R. Topical tretinoin in combination with topical clindamycin in the treatment of acne. J Clin Dermatol 1994;September(suppl):13-18.
23. Shalita AR. Topical tretinoin and a combination formulation of topical benzoyl peroxide and erythromycin in the management of acne. J Clin Dermatol 1994;September-(suppl): 19-26.
24. Plewig G, Kligman AM. Acne morphogenesis and treatment. New York: Springer, 1975:290.
25. Kligman AM, Fulton JE Jr, Plewig G. Topical vitamin A acid in acne vulgaris. Arch Dermatol 1969;99:469-476.
26. Shroot B, Michel S. Pharmacology and chemistry of adapalene. J Am Acad Dermatol 1997;36:S96-103.
27. Guzzo CA, Lazarus GS, Werth VP. Dermatologic pharmacology. In: Hardman JG, et al., eds. Pharmacological basis of therapeutics, 9th ed. New York: McGraw-Hill, 1996: 1598-1602.
28. Bernard BA. Adapalene, a new chemical entity with retinoid activity. Skin Pharmacol 1993;6(suppl):61-69.
29. Jamoulle JC, Lamaud E, Grandjean L, et al. Follicular penetration, distribution, and migration of CD 271, a new naphthoic acid derivative for topical acne treatment. In: Reichert U, Shroot B, eds. Pharmacology of the skin, Vol. 3: Pharmacology of retinoids in the skin. Basel; New York: Karger, 1989:198-200.
30. Data on file, Allergan.
31. Eady EA, Cove JH. Topical antibiotic therapy: current status and future prospects. Drugs Exp Clin Res 1990;16: 423-433.
32. Eiewski BE, et al. In vivo suppression of neutrophil chemotaxis by systemically and topically administered tetracycline. J Am Acad Dermatol 1983;8:807-812.
33. Mills OH, Marpies RR, Kligman AM. Acne vulgaris: oral therapy with tetracycline and topical therapy with vitamin A acid. Arch Dermatol 1972;106:200-203.
34. Cunliffe WJ. Topical erythromycin: clinical and laboratory studies. In: Marcis R, ed. Topical antibiotics in acne. London: Martin Dunhill, 1989.
35. Eady EA, Holland KT, Cunliffe WJ. Should antibiotics be used for the treatment of acne vulgaris? Br J Dermatol 1982;107:235-246.
36. Kamasaka BH, Odland PB. Acne vulgaris: topical and systemic therapies. Postgrad Med 1992;92:181-194.
37. Kligman AM, et al. Acne therapy with tretinoin in combination with antibiotics. Acta Dermatol Venereol (Stockh) 1975;74(suppl):111-115.
38. Leyden JJ, Shalita AR. Rational therapy for acne vulgaris. An update on topical treatment. J Am Acad Dermatol 1986;15:907-915.
39. Fulton JE Jr, Farad-Bakeshandeh A, Bradley S. Studies on the mechanism of action of topical benzoyl peroxide and vitamin A acid in acne vulgaris. J Cutan Pathol 1974;1; 191-200.
40. Hurwitz S. Acne vulgaris: pathogenesis and management. Pediatr Rev 1994;15:47-52.
41. Hurwitz S. The combined effect of vitamin A acid and benzoyl peroxide in the treatment of acne. Cutis 1976;17: 585-590.
42. Rietschel R, Duncan SH. Comparison of topical clindamycin phosphate, benzoyl peroxide, and a combination of the two for the treatment of acne vulgaris. Int J Dermatol 1983;22:41-43.
43. Shalita AR, et al. A multicenter, double-blind controlled study of the combination of erythromycin/benzoyl peroxide, erythromycin alone, and benzoyl peroxide alone in the treatment of acne vulgaris. Cutis 1992;49:1-4.
44. Verschoore M, et al. Efficacy and safety of CD 271 alcoholic gels in the topical treatment of acne vulgaris. Br J Dermatol 1991;124:368-371.